Skip to main content
. Author manuscript; available in PMC: 2007 Sep 27.
Published in final edited form as: J Pain. 2007 May 29;8(8):637–649. doi: 10.1016/j.jpain.2007.04.004

Figure 6. NGF and GDNF did not alter formalin responses or formalin-induced spinal Fos expression in nondiabetic mice.

Figure 6

The behavioral responses (A) and Fos expression (B, C) of nondiabetic mice receiving 2 weeks of daily intrathecal injections of vehicle (CSF), NGF, or GDNF. A) At 5 weeks post-STZ, statistical analysis did not show an effect of treatment group on the Phase 1 or 2 behavioral responses over time. B) Neither NGF nor GDNF treatment altered the overall number of Fos-positive neurons per section compared to CSF-treated mice. C) NGF and GDNF treatment did not change the number of Fos-positive neurons within any laminar region. Data plotted as means +/− standard error of mean.